Chlamydia MOMP selected as 3rd Model Antigen So far, within the ADITEC project, the research partners worked with two different antigens in their studies: H56 from Mycobacterium tuberculosis and H1 from influenza virus. After a rigorous selection process, the MOMP […]
Aditec partner Novartis Vaccines Institute for Global Health (NVGH) organizes, together with University of Siena and Novartis Vaccines Academy, the 3rd Master in Vaccinology and Pharmaceutical Clinical Development in Siena Italy The Master is an eighteen month training programme aimed […]
Welcome to our first newsletter! Dear partner, I’m happy to send you the first electronic newsletter of ADITEC, the EU/FP7 funded project about Advanced Immunization Technologies. With this letter we want to update our partners, allies and everyone else who’s […]